EUVIMEDEUVIMED entdecken
Crossref

MCM10 promotes hepatocellular carcinoma progression through cyclin D1 regulation

Yi-Ru Chen, Gang Wang, Long-Jun He, Huo-Wang Ye, Li-Feng Wang, Dan-Dan Zou, Mei-Qian Wang, Hui-Wen Xie, Sen-Lin Zhu, Xin-Ying Wang

World Journal of Gastrointestinal Oncology · 15.08.2026 · 18 (8)

DOI: 10.4251/wjgo.119834 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Gastrointestinal Oncology, online erschienen am 15.08.2026. Verfasst von Yi-Ru Chen und 9 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Eukaryotic DNA replication constitutes a core mechanism underlying cellular proliferation, whereas unrestrained DNA replication is widely recognized as a key driver of tumorigenesis. MCM10 plays an essential role in the initiation of DNA replication. AIM To explore the biological function of MCM10 in the progression of hepatocellular carcinoma (HCC). METHODS Immunohistochemical staining and large-scale data mining were employed to assess the association between MCM10 expression and clinical pathological characteristics in HCC. Furthermore, in vitro and in vivo experiments were performed to investigate the biological roles and underlying molecular mechanisms of MCM10 in HCC. RESULTS Elevated MCM10 expression was significantly associated with adverse clinicopathological features in HCC. High MCM10 expression levels predicted poorer clinical outcomes among patients with HCC. Functionally, upregulation of MCM10 significantly accelerated cellular proliferation in vitro and tumor formation in vivo . Conversely, MCM10 knockdown markedly suppressed HCC cell proliferation and oncogenic activity. Mechanistic investigations revealed that MCM10 promoted cell cycle progression by activating the cyclin D1-CDK4/6 signaling axis. Notably, time-dependent receiver operating characteristic curve analysis demonstrated that the combined detection of MCM10 and cyclin D1 exhibited a consistently modest advantage over either marker alone in predicting patient survival throughout the observation period. CONCLUSION MCM10 facilitates HCC progression by activating the cyclin D1-CDK4/6 pathway, supporting a synergistic prognostic significance of the MCM10-cyclin D1 signature for HCC.

Zitieren

APA

Chen, Y., Wang, G., He, L., Ye, H., Wang, L., Zou, D., Wang, M., Xie, H., Zhu, S., & Wang, X. (2026). MCM10 promotes hepatocellular carcinoma progression through cyclin D1 regulation. World Journal of Gastrointestinal Oncology, 18(8). https://doi.org/10.4251/wjgo.119834

Vancouver

Chen Y, Wang G, He L, Ye H, Wang L, Zou D, et al. MCM10 promotes hepatocellular carcinoma progression through cyclin D1 regulation. World Journal of Gastrointestinal Oncology. 2026;18(8). doi:10.4251/wjgo.119834

BibTeX
@article{Chen2026,
  author = {Chen, Yi-Ru and Wang, Gang and He, Long-Jun and Ye, Huo-Wang and Wang, Li-Feng and Zou, Dan-Dan and Wang, Mei-Qian and Xie, Hui-Wen and Zhu, Sen-Lin and Wang, Xin-Ying},
  title = {MCM10 promotes hepatocellular carcinoma progression through cyclin D1 regulation},
  journal = {World Journal of Gastrointestinal Oncology},
  year = {2026},
  volume = {18},
  number = {8},
  doi = {10.4251/wjgo.119834}
}
Kostenlos starten →